Impact of GxAlert on the management of rifampicin-resistant tuberculosis patients, Port Moresby, Papua New Guinea

GxAlert is an automatic electronic notification service that provides immediate Xpert® MTB/RIF testing results

Abstract

Setting

GxAlert is an automatic electronic notification service that provides immediate Xpert® MTB/RIF testing results. It was implemented for the notification of patients with rifampicin resistant-tuberculosis (RR-TB) at Port Moresby General Hospital, Port Moresby, Papua New Guinea, in May 2015.

Objective

To determine if there were differences in pre-treatment attrition, the time to treatment initiation and patient outcomes in the 12 months pre- and post-introduction of GxAlert for RR-TB patients.

This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (»Ê¹ÚÌåÓýapp Union)

Citation

Banamu JK, Lavu E, Johnson K, Moke R, Majumdar SS, Takarinda KC, Commons RJ. Impact of GxAlert on the management of rifampicin-resistant tuberculosis patients, Port Moresby, Papua New Guinea. Public Health Action. 2019;9(1):S19�24.

Updates to this page

Published 28 October 2019